ABSTRACT
El Trastorno por déficit atencional con hiperactividad (TDAH) es un trastorno crónico, del neurodesarrollo con una prevalencia de 5,29% en la población pediátrica. Las manifestaciones clínicas incluyen síntomas de hiperactividad, impulsividad y desatención que conducen a un deterioro funcional en el desarrollo social, familiar y escolar. Si bien en los últimos años ha habido un aumento en su reconocimiento, la heterogeneidad clínica y la alta comorbilidad pueden obstaculizar su diagnóstico. En el presente trabajo se revisarán diferentes aspectos de la presentación clínica y del abordaje terapéutico de este trastorno
The attention hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder with a prevalence of 5.24% in pediatric population. The clinical presentation includes symptoms of hyperactivity, impulsivity and inattention with a functional impairment in social, family and scholar development. Even though in the last years it has been well recognized, its clinical heterogeneity and high comorbidity hampers its diagnosis. In this article different aspects of the clinical presentation and therapeutic approach of this disorder will be reviewed
Subject(s)
Humans , Child , Adolescent , Attention Deficit Disorder with Hyperactivity/psychology , Child Health , Adolescent Health , Attention Deficit Disorder with Hyperactivity/diagnosis , Attention Deficit Disorder with Hyperactivity/therapyABSTRACT
The Banff classification was introduced to achieve uniformity in the assessment of renal allograft biopsies. The primary aim of this study was to evaluate the impact of specimen adequacy on the Banff classification. All renal allograft biopsies obtained between July 2010 and June 2012 for suspicion of acute rejection were included. Pre-biopsy clinical data on suspected diagnosis and time from renal transplantation were provided to a nephropathologist who was blinded to the original pathological report. Second pathological readings were compared with the original to assess agreement stratified by specimen adequacy. Cohen's kappa test and Fisher's exact test were used for statistical analyses. Forty-nine specimens were reviewed. Among these specimens, 81.6% were classified as adequate, 6.12% as minimal, and 12.24% as unsatisfactory. The agreement analysis among the first and second readings revealed a kappa value of 0.97. Full agreement between readings was found in 75% of the adequate specimens, 66.7 and 50% for minimal and unsatisfactory specimens, respectively. There was no agreement between readings in 5% of the adequate specimens and 16.7% of the unsatisfactory specimens. For the entire sample full agreement was found in 71.4%, partial agreement in 20.4% and no agreement in 8.2% of the specimens. Statistical analysis using Fisher's exact test yielded a P value above 0.25 showing that - probably due to small sample size - the results were not statistically significant. Specimen adequacy may be a determinant of a diagnostic agreement in renal allograft specimen assessment. While additional studies including larger case numbers are required to further delineate the impact of specimen adequacy on the reliability of histopathological assessments, specimen quality must be considered during clinical decision making while dealing with biopsy reports based on minimal or unsatisfactory specimens.
Subject(s)
Humans , Male , Female , Allografts/classification , Allografts/pathology , Graft Rejection/pathology , Kidney/pathology , Biopsy , Observer Variation , Reproducibility of Results , Retrospective Studies , Kidney Transplantation/adverse effectsABSTRACT
En el presente trabajo hemos controlado 30 pacientes con paracoccidioidomicosis, 17 de ellos fueron diagnosticados en el ultimo ano, todos varones, edad promedio de 44 anos al inicio de su enfermedad, con una demora promedio a la consulta de 8 meses.Predominan las formas clinicas mixtas (cutaneo-mucosa-pulmonar; cutaneo-mucosa y mucopulmonar) en un 84% de los casos; la mayoria provienen de areas rurales o suburbanas. El 85% fueron tratados con ketoconazol (derivado imidazolico con accion antifungica de amplio espectro) con muy buenos resultados. Se realizan controles clinicos, laboratoriales y serologicos periodicos para evaluar la mejoria, la regresion clinica de las lesiones precede a la negativizacion serologica y no hemos encontrado alterado el hepatograma de estos pacientes